The Latest Cardiac and Vascular News
New machine learning algorithm to support clinical decision-making in the early detection of cardiovascular disease OAKLAND, Calif., Sept. 20, 2022 /PRNewswire/ — Eko, a digital health company applying machine learning in the fight against heart and lung disease, today announced that it was awarded a $2.7 million Small Business Innovation Research (SBIR) Direct Phase II […]
Patent continues to strengthen and expand IP portfolio Southlake, Texas, Sept. 20, 2022 (GLOBE NEWSWIRE) — Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), a medical technology company focused on applying innovative AI-based technology to an ECG (also known as an EKG) to significantly expand and improve an […]
Study of the Paradise™ Ultrasound Renal Denervation System Shows Significant Reduction in Blood Pressure in Patients with Uncontrolled Hypertension September 18, 2022 11:44 AM Eastern Daylight Time PALO ALTO, Calif.–(BUSINESS WIRE)–ReCor Medical, Inc. (“ReCor”), a wholly owned subsidiary of Otsuka Medical Devices Co., Ltd., today announced the detailed results from […]
Patent Opens Pathway to a Disruptive Ischemia and Arrhythmia Detection ECG Patch Product SANTA CLARA, Calif.–(BUSINESS WIRE)–HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector ECG platform for heart attack detection anytime, anywhere, announced today that its patent for a 12-lead electrocardiogram (ECG) patch […]
ST. LOUIS, Sept. 13, 2022 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that Overland Park Regional Medical Center (OPRMC) is establishing its second robotic program for the treatment of heart rhythm disorders. OPRMC, a part of HCA Midwest […]
Southlake, Texas, Sept. 12, 2022 (GLOBE NEWSWIRE) — Heart Test Laboratories, Inc d.b.a HeartSciences (NASDAQ: HSCS), a medical technology company focused on applying innovative AI-based technology to an ECG (also known as an EKG) to significantly expand and improve an ECG’s clinical usefulness by detecting cardiac dysfunction, today announced that […]
SARASOTA, Fla., Sept. 8, 2022 /PRNewswire/ — PaceMate, the leading digital healthcare company in cardiac data management and remote monitoring, is pleased to announce the PaceMate Ecosystem—a strategic development of its all-in-one data platform—PaceMate™LIVE—to expand beyond cardiac remote monitoring software and service to offer full interoperability and maximized productivity for device clinics, […]
This is the second Fast Track designation issued by the FDA for abelacimab Abelacimab is a dual-acting, once-monthly, fully human monoclonal antibody targeting both Factor XI and Factor XIa with high affinity and selectivity CAMBRIDGE, Mass., Sept. 08, 2022 (GLOBE NEWSWIRE) — Anthos Therapeutics, a clinical-stage biotechnology company developing innovative therapies for […]
US Arm of IMPACT II Study Will Ascertain Reduction of Esophageal Thermal Injury During Cardiac RF Ablation Procedures CHICAGO–(BUSINESS WIRE)–The US Food and Drug Administration (FDA) has granted an Investigational Device Exemption (IDE) to Attune Medical to evaluate the company’s ensoETM in the reduction of esophageal thermal injury during cardiac radiofrequency ablation […]
Study shows 97.3% accuracy in identifying arrhythmia source locations in nine atrial and ventricular arrhythmias and pacing types across all four heart chambers. September 07, 2022 08:34 AM Eastern Daylight Time SAN DIEGO–(BUSINESS WIRE)–Vektor Medical, the developer of the world’s first technology to rapidly map cardiac arrhythmias using only 12-lead […]
